- Home
- YSXT vs HLVX Comparison
YSXT vs HLVX Comparison
Compare YSXT & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- HLVX
- Stock Information
- Founded
- YSXT 2011
- HLVX 2020
- Country
- YSXT China
- HLVX United States
- Employees
- YSXT N/A
- HLVX N/A
- Industry
- YSXT Automotive Aftermarket
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- HLVX Health Care
- Exchange
- YSXT Nasdaq
- HLVX Nasdaq
- Market Cap
- YSXT 104.6M
- HLVX 93.1M
- IPO Year
- YSXT 2024
- HLVX 2022
- Fundamental
- Price
- YSXT $2.70
- HLVX $1.94
- Analyst Decision
- YSXT
- HLVX Hold
- Analyst Count
- YSXT 0
- HLVX 5
- Target Price
- YSXT N/A
- HLVX $2.33
- AVG Volume (30 Days)
- YSXT 256.5K
- HLVX 323.4K
- Earning Date
- YSXT 01-01-0001
- HLVX 11-07-2024
- Dividend Yield
- YSXT N/A
- HLVX N/A
- EPS Growth
- YSXT N/A
- HLVX N/A
- EPS
- YSXT 0.21
- HLVX N/A
- Revenue
- YSXT $58,546,729.00
- HLVX N/A
- Revenue This Year
- YSXT N/A
- HLVX N/A
- Revenue Next Year
- YSXT N/A
- HLVX N/A
- P/E Ratio
- YSXT $13.73
- HLVX N/A
- Revenue Growth
- YSXT 18.92
- HLVX N/A
- 52 Week Low
- YSXT $2.60
- HLVX $1.55
- 52 Week High
- YSXT $5.52
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- HLVX 53.94
- Support Level
- YSXT N/A
- HLVX $1.95
- Resistance Level
- YSXT N/A
- HLVX $1.94
- Average True Range (ATR)
- YSXT 0.00
- HLVX 0.08
- MACD
- YSXT 0.00
- HLVX -0.01
- Stochastic Oscillator
- YSXT 0.00
- HLVX 40.74
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.